TRML / Tourmaline Bio, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Tourmaline Bio, Inc.
US ˙ NasdaqGS ˙ US89157D1054
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier61.893.898 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Tourmaline Bio, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TRML / Tourmaline Bio, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-08-21 Kulkarni Sandeep Chidambar 1.779 14,8500 1.779 14,8500 26.418 57 29.1300 25.404 96,16
2024-08-16 Kulkarni Sandeep Chidambar 5.221 13,7900 5.221 13,7900 71.998
2024-01-29 MCDADE MARK 100.000 32,5000 100.000 32,5000 3.250.000
2023-11-17 Thiara Parvinder 1.000 17,3100 1.000 17,3100 17.310
2023-11-17 Kulkarni Sandeep Chidambar 4.000 16,9900 4.000 16,9900 67.960
2023-10-27 Castelein Caley 15.800 14,5500 15.800 14,5500 229.890
2023-10-26 Kulkarni Sandeep Chidambar 5.000 12,2500 5.000 12,2500 61.250
2023-10-25 Thiara Parvinder 2.000 12,1200 2.000 12,1200 24.240
2023-10-25 Castelein Caley 4.200 12,0700 4.200 12,0700 50.694

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRML / Tourmaline Bio, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TRML / Tourmaline Bio, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-06-14 Ildstad Suzanne 12.942 2,4914 12.942 2,4914 32.244 7 2.2000 -3.771 -11,69
2023-06-13 Ildstad Suzanne 14.208 2,5576 14.208 2,5576 36.338
2023-06-12 Ildstad Suzanne 16.870 2,5919 16.870 2,5919 43.725
2023-06-09 Ildstad Suzanne 25.419 2,4642 25.419 2,4642 62.637
2023-06-08 Ildstad Suzanne 40.642 2,4795 40.642 2,4795 100.772
2023-06-07 Ildstad Suzanne 75.001 2,3879 75.001 2,3879 179.095
2023-06-06 Ildstad Suzanne 25.549 2,5283 25.549 2,5283 64.596
2023-06-05 Ildstad Suzanne 7.841 2,5194 7.841 2,5194 19.755
2023-06-02 Ildstad Suzanne 15.818 2,5045 15.818 2,5045 39.616

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRML / Tourmaline Bio, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-10-28 2025-10-28 4 Kulkarni Sandeep Chidambar By Gilead Capital, LP TRML Common Stock U - Other I -7.000 0
2025-10-28 2025-10-28 4 Kulkarni Sandeep Chidambar TRML Common Stock D - Sale to Issuer D -30.387 0
2025-10-28 2025-10-28 4 Kulkarni Sandeep Chidambar TRML Common Stock U - Other D -724.664 30.387
2025-10-28 2025-10-28 4 Robinson Ryan F. TRML Common Stock U - Other D -14.366 0
2025-10-28 2025-10-28 4 MIDDLEKAUFF W BRADFORD TRML Common Stock D - Sale to Issuer D -8.213 0
2025-10-28 2025-10-28 4 MIDDLEKAUFF W BRADFORD TRML Common Stock U - Other D -60.988 8.213
2025-10-28 2025-10-28 4 Jones Susan Dana TRML Common Stock D - Sale to Issuer D -3.152 0
2025-10-28 2025-10-28 4 Jones Susan Dana TRML Common Stock U - Other D -19.782 3.152
2025-10-28 2025-10-28 4 Johnson Kevin Bruce TRML Common Stock D - Sale to Issuer D -11.046 0
2025-10-28 2025-10-28 4 Johnson Kevin Bruce TRML Common Stock U - Other D -40.538 11.046
2025-10-28 2025-10-28 4 Castelein Caley By KVP Capital, LP TRML Common Stock U - Other I -431.939 0
2025-10-28 2025-10-28 4 Castelein Caley TRML Common Stock U - Other D -515.997 0
2025-10-28 2025-10-28 4 KANTOFF AARON TRML Common Stock U - Other D -88.281 0
2025-10-28 2025-10-28 4 MCDADE MARK By Qiming U.S. Healthcare Fund III,L.P. TRML Common Stock U - Other I -448.431 0
2025-10-28 2025-10-28 4 MCDADE MARK By Qiming U.S. Healthcare Fund II,L.P. TRML Common Stock U - Other I -110.083 0
2025-10-28 2025-10-28 4 MCDADE MARK By Qiming U.S. Healthcare Fund I,L.P. TRML Common Stock U - Other I -183.177 0
2025-10-28 2025-10-28 4 MCDADE MARK TRML Common Stock U - Other D -518 0
2025-10-28 2025-10-28 4 Srivastava Sapna TRML Common Stock U - Other D -518 0
2025-10-28 2025-10-28 4 Thiara Parvinder TRML Common Stock U - Other D -83.782 0
2025-10-28 3 NOVARTIS AG TRML Common Stock, par value $0.0001 I 24.030.382
2025-10-24 2025-10-24 4 KANTOFF AARON TRML Common Stock G - Gift D -5.000 88.281
2025-10-24 2025-10-22 4 Robinson Ryan F. TRML Common Stock M - Exercise D 13,9200 14.366 200 14.366
2025-10-24 2025-10-22 4 Kulkarni Sandeep Chidambar TRML Common Stock M - Exercise D 7,9000 25.316 200 755.051
2025-10-17 2025-10-15 4 Castelein Caley TRML Common Stock G - Gift D -522 515.997
2025-10-17 2025-10-15 4 Johnson Kevin Bruce TRML Common Stock G - Gift D -6.250 51.584
2025-09-09 2025-09-05 4 KANTOFF AARON TRML Common Stock M - Exercise D 9,4600 10.000 95 93.281
2025-09-09 2025-09-05 4 KANTOFF AARON TRML Common Stock M - Exercise D 0,1300 37.890 5 83.281
2024-08-22 2024-08-21 4 Kulkarni Sandeep Chidambar By Gilead Capital, LP TRML Common Stock P - Purchase I 14,8500 1.779 26 7.000
2024-08-20 2024-08-16 4 Kulkarni Sandeep Chidambar By Gilead Capital, LP TRML Common Stock P - Purchase I 13,7900 5.221 72 5.221
2024-01-31 2024-01-29 4 MCDADE MARK By Qiming U.S. Healthcare Fund III,L.P. TRML Common Stock P - Purchase I 32,5000 100.000 3.250 448.431
2023-11-20 2023-11-17 4 Kulkarni Sandeep Chidambar TRML Common Stock P - Purchase D 16,9900 4.000 68 729.735
2023-11-20 2023-11-17 4 Thiara Parvinder TRML Common Stock P - Purchase D 17,3100 1.000 17 83.782
2023-10-27 2023-10-27 4 Castelein Caley TRML Common Stock P - Purchase D 14,5500 15.800 230 516.519
2023-10-27 2023-10-25 4 Castelein Caley TRML Common Stock P - Purchase D 12,0700 4.200 51 500.719
2023-10-26 2023-10-26 4 Kulkarni Sandeep Chidambar TRML Common Stock P - Purchase D 12,2500 5.000 61 725.735
2023-10-26 2023-10-24 4 Kulkarni Sandeep Chidambar TRML Common Stock P - Purchase D 10,6800 4.650 50 720.735
2023-10-26 2023-10-24 4 KANTOFF AARON TRML Common Stock P - Purchase D 11,8600 7.500 89 45.391
2023-10-26 2023-10-25 4 Thiara Parvinder TRML Common Stock P - Purchase D 12,1200 2.000 24 82.782
2023-10-26 2023-10-24 4 Thiara Parvinder TRML Common Stock P - Purchase D 10,6600 5.000 53 80.782
2023-10-23 2023-10-19 4 Thiara Parvinder TRML Common Stock A - Award D 75.782 75.782
2023-10-23 2023-10-19 4 Srivastava Sapna TRML Common Stock A - Award D 518 518
2023-10-23 2023-10-19 4 MIDDLEKAUFF W BRADFORD TRML Common Stock A - Award D 69.201 69.201
2023-10-23 2023-10-19 4 MCDADE MARK TRML Common Stock A - Award D 518 518
2023-10-23 2023-10-19 4 MCDADE MARK By Qiming U.S. Healthcare Fund III,L.P. TRML Common Stock A - Award I 348.431 348.431
2023-10-23 2023-10-19 4 Kulkarni Sandeep Chidambar TRML Common Stock A - Award D 716.085 716.085
2023-10-23 2023-10-19 4 KANTOFF AARON TRML Common Stock A - Award D 37.891 37.891
2023-10-23 2023-10-19 4 Jones Susan Dana TRML Common Stock A - Award D 22.934 22.934
2023-10-23 2023-10-19 4 Johnson Kevin Bruce TRML Common Stock A - Award D 57.834 57.834
2023-10-23 2023-10-19 4 CHYUNG YUNG H. TRML Common Stock A - Award D 56.836 56.836
2023-10-23 2023-10-19 4 Castelein Caley By KVP Capital, LP TRML Common Stock A - Award I 458.039 458.039
2023-10-23 2023-10-19 4 Castelein Caley TRML Common Stock A - Award D 496.519 496.519
2023-07-06 2023-07-03 4 Requadt Scott TALS Common Stock F - Taxes D 3,0800 -11.786 -36 578.403
2023-07-06 2023-07-03 4 Fenton Mary Kay TALS Common Stock F - Taxes D 3,0800 -12.946 -40 68.054
2023-06-14 2023-06-14 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,4914 -12.942 -32 3.771.392
2023-06-14 2023-06-13 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,5576 -14.208 -36 3.784.334
2023-06-14 2023-06-12 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,5919 -16.870 -44 3.798.542
2023-06-09 2023-06-09 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,4642 -25.419 -63 3.815.412
2023-06-09 2023-06-08 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,4795 -40.642 -101 3.840.831
2023-06-09 2023-06-07 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,3879 -75.001 -179 3.881.473
2023-06-07 2023-06-06 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,5283 -25.549 -65 2.756.474
2023-06-07 2023-06-05 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,5194 -7.841 -20 2.782.023
2023-06-05 2023-06-02 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,5045 -15.818 -40 2.789.864
2023-06-05 2023-06-01 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,5569 -15.713 -40 2.805.682
2023-04-25 2023-04-21 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,3481 -15.004 -35 2.821.395
2023-04-21 2023-04-20 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,3263 -46.990 -109 2.836.399
2023-04-21 2023-04-19 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,1632 -21.753 -47 2.883.389
2023-04-19 2023-04-18 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,1500 -49.211 -106 2.905.142
2023-04-19 2023-04-17 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,1402 -99.771 -214 2.954.353
2023-04-07 2023-03-17 4/A Ildstad Suzanne TALS Common Stock S - Sale D 2,0643 -10.436 -22 3.054.124
2023-04-07 2023-03-03 4/A Ildstad Suzanne TALS Common Stock S - Sale D 2,0559 -6.806 -14 3.064.560
2023-04-07 2023-03-01 4/A Ildstad Suzanne TALS Common Stock S - Sale D 2,0500 -29 -0 3.071.366
2023-04-07 2023-02-21 4/A Ildstad Suzanne TALS Common Stock S - Sale D 2,0529 -3.500 -7 3.071.395
2023-04-07 2023-02-17 4/A Ildstad Suzanne TALS Common Stock S - Sale D 2,0503 -3.612 -7 3.074.895
2023-04-07 2023-02-16 4/A Ildstad Suzanne TALS Common Stock S - Sale D 2,0551 -2.939 -6 3.078.507
2023-03-20 2023-03-17 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,0643 -10.436 -22 3.054.124
2023-03-07 2023-03-03 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,0559 -6.806 -14 3.064.560
2023-03-02 2023-03-01 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,0500 -29 -0 3.071.366
2023-02-23 2023-02-21 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,0529 -3.500 -7 3.071.395
2023-02-21 2023-02-17 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,0503 -3.612 -7 3.074.895
2023-02-21 2023-02-16 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,0551 -2.939 -6 3.078.507
2023-02-03 2022-12-30 4 Requadt Scott TALS Common Stock A - Award D 0,8670 4 0 590.193
2022-09-13 2022-09-10 4 Zdanowski Michael TALS Common Stock A - Award D 120.000 121.470
2022-09-13 2022-09-10 4 Requadt Scott TALS Common Stock A - Award D 80.000 590.189
2022-09-13 2022-09-10 4 Krieger Nancy TALS Common Stock A - Award D 80.000 330.233
2022-09-13 2022-09-10 4 Fenton Mary Kay TALS Common Stock A - Award D 80.000 81.000
2022-09-13 2022-07-25 4/A Nader Francois By FN TALS LLC TALS Common Stock J - Other I 138.500 386.932
2022-09-13 2022-07-25 4/A Nader Francois TALS Common Stock J - Other D -138.500 0
2022-09-13 2022-07-21 4/A Nader Francois TALS Common Stock P - Purchase D 3,7200 36.500 136 138.500
2022-09-13 2022-07-21 4/A Nader Francois By FN TALS LLC TALS Common Stock J - Other I 248.432 248.432
2022-09-13 2022-07-21 4/A Nader Francois By Francois Nader 2020 Trust TALS Common Stock J - Other I -248.432 147.255
2022-09-13 2022-07-20 4/A Nader Francois TALS Common Stock P - Purchase D 3,6200 52.000 188 102.000
2022-09-13 2022-07-19 4/A Nader Francois TALS Common Stock P - Purchase D 3,5200 50.000 176 50.000
2022-08-23 2022-08-22 4 Ildstad Suzanne TALS Common Stock S - Sale D 2,8000 -525.000 -1.470 3.081.446
2022-08-02 2022-07-29 4 Requadt Scott TALS Common Stock P - Purchase D 4,2500 39.382 167 508.680
2022-07-28 2022-07-28 4 Requadt Scott TALS Common Stock P - Purchase D 4,2500 3.090 13 469.298
2022-07-28 2022-07-26 4 Requadt Scott TALS Common Stock P - Purchase D 4,2400 5.528 23 466.208
2022-07-26 2022-07-22 4 Requadt Scott TALS Common Stock P - Purchase D 3,7497 9.444 35 460.680
2022-07-25 2022-07-25 4 Nader Francois By FN TALS LLC TALS Common Stock J - Other I 138.500 386.932
2022-07-25 2022-07-25 4 Nader Francois TALS Common Stock J - Other D -138.500 0
2022-07-25 2022-07-21 4 Nader Francois TALS Common Stock P - Purchase D 3,7200 36.500 136 138.500
2022-07-25 2022-07-21 4 Nader Francois By FN TALS LLC TALS Common Stock J - Other I 248.432 248.432
2022-07-25 2022-07-21 4 Nader Francois By Francois Nader 2020 Trust TALS Common Stock J - Other I -248.432 87.735
2022-07-25 2022-07-20 4 Nader Francois TALS Common Stock P - Purchase D 3,6200 52.000 188 102.000
2022-07-25 2022-07-19 4 Nader Francois TALS Common Stock P - Purchase D 3,5200 50.000 176 50.000
2022-05-17 2022-05-16 4 Smith Karen L. TALS Stock Option (Right to Buy) A - Award D 6,54 29.002 29.002
2022-02-02 2022-02-01 4 Ildstad Suzanne TALS Stock Option (Right to Buy) A - Award D 9,10 150.000 150.000
2022-02-02 2021-11-17 4 Ildstad Suzanne By GRAT TALS Common Stock G - Gift I 1.200.000 1.200.000
2022-02-02 2021-11-17 4 Ildstad Suzanne TALS Common Stock G - Gift D -1.200.000 3.606.446
2022-02-02 2022-02-01 4 Krieger Nancy TALS Stock Option (Right to Buy) A - Award D 9,10 190.000 190.000
2022-02-02 2022-02-01 4 Requadt Scott TALS Stock Option (Right to Buy) A - Award D 9,10 500.000 500.000
2022-02-02 2021-12-31 4 Requadt Scott TALS Common Stock A - Award D 13,0000 1.470 19 451.236
2022-02-02 2022-02-01 4 Zdanowski Michael TALS Stock Option (Right to Buy) A - Award D 9,10 200.000 200.000
2022-02-02 2021-12-31 4 Zdanowski Michael TALS Common Stock A - Award D 13,0000 1.470 19 1.470
2022-02-02 2022-02-01 4 Fenton Mary Kay TALS Stock Option (Right to Buy) A - Award D 9,10 200.000 200.000
2022-02-02 2021-12-31 4 Fenton Mary Kay TALS Common Stock A - Award D 13,0000 1.000 13 1.000
2021-12-16 2021-12-15 4 Nader Francois By Francois Nader 2020 Trust TALS Common Stock G - Gift I -59.520 336.167
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -135.334 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -676.774 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -366.918 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -562.891 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -278.707 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -696.767 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -717.160 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -3.586.364 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -1.944.371 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -2.982.874 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -1.476.924 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -3.692.307 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Series A Convertible Preferred Stock C - Conversion I -26.000.000 0
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 701 12 160.044
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 3.507 60 800.353
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 1.902 32 433.917
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 2.917 50 665.676
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 1.444 25 329.598
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 3.611 61 823.997
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 15.918 271 4.875.730
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 25.296 159.343
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 126.499 796.846
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 68.582 432.015
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 105.213 662.759
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 52.094 328.154
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 130.236 820.386
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 134.047 134.047
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 670.347 670.347
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 363.433 363.433
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 557.546 557.546
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 276.060 276.060
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 690.150 690.150
2021-05-14 2021-05-11 4 Clarus Lifesciences III, L.P. See Footnotes TALS Common Stock C - Conversion I 4.859.812 4.859.812
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -135.334 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -676.774 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -366.918 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -562.891 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -278.707 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series B Convertible Preferred Stock C - Conversion I -696.767 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -717.160 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -3.586.364 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -1.944.371 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -2.982.874 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -1.476.924 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series A-1 Convertible Preferred Stock C - Conversion I -3.692.307 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Series A Convertible Preferred Stock C - Conversion I -26.000.000 0
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 701 12 160.044
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 3.507 60 800.353
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 1.902 32 433.917
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 2.917 50 665.676
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 1.444 25 329.598
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 3.611 61 823.997
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock P - Purchase I 17,0000 15.918 271 4.875.730
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 25.296 159.343
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 126.499 796.846
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 68.582 432.015
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 105.213 662.759
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 52.094 328.154
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 130.236 820.386
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 134.047 134.047
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 670.347 670.347
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 363.433 363.433
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 557.546 557.546
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 276.060 276.060
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 690.150 690.150
2021-05-13 2021-05-11 4 Clarus Defined Exit I, L.P. See Footnotes TALS Common Stock C - Conversion I 4.859.812 4.859.812
2021-05-11 2021-05-11 4 Agarwala Sandip TALS Series B Preferred Stock C - Conversion I -406.338 0
2021-05-11 2021-05-11 4 Agarwala Sandip TALS Series A-1 Preferred Stock C - Conversion I -1.271.027 0
2021-05-11 2021-05-11 4 Agarwala Sandip TALS Series A Preferred Stock C - Conversion I -1.308.410 0
2021-05-11 2021-05-11 4 Agarwala Sandip TALS Common Stock P - Purchase I 17,0000 235.000 3.995 3.220.775
2021-05-11 2021-05-11 4 Agarwala Sandip TALS Common Stock C - Conversion I 2.985.775 2.985.775
2021-05-11 2021-05-11 4 Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. TALS Series B Preferred Stock C - Conversion I -406.338 0
2021-05-11 2021-05-11 4 Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. TALS Series A-1 Preferred Stock C - Conversion I -1.271.027 0
2021-05-11 2021-05-11 4 Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. TALS Series A Preferred Stock C - Conversion I -1.308.410 0
2021-05-11 2021-05-11 4 Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. TALS Common Stock P - Purchase I 17,0000 235.000 3.995 3.220.775
2021-05-11 2021-05-11 4 Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. TALS Common Stock C - Conversion I 2.985.775 2.985.775
2021-05-06 3 Requadt Scott TALS Common Stock D 449.766
2021-05-06 3 Requadt Scott TALS Common Stock I 449.766
2021-05-06 3 Krieger Nancy TALS Common Stock D 250.233
2021-05-06 3 Nader Francois TALS Common Stock D 395.687
2021-05-06 3 Ildstad Suzanne TALS Common Stock I 654.205
2021-05-06 3 Ildstad Suzanne TALS Common Stock I 654.205
2021-05-06 3 Ildstad Suzanne TALS Common Stock D 4.806.446
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista